Search - tctmd.com

Displaying 61 - 80 of 83

Sort: Relevancy | Date

KARDIA-2: Zilebesiran Drops BP on Top of Common Antihypertensives

News Conference News ACC 2024

KARDIA-2: Zilebesiran Drops BP on Top of Common Antihypertensives

April 11, 2024

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

News Conference News ACC 2024

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

April 10, 2024

Full AEGIS-II Results: Raising HDL With Apo A-I No Help After Acute MI

News Conference News ACC 2024

Full AEGIS-II Results: Raising HDL With Apo A-I No Help After Acute MI

Yael L. Maxwell

April 06, 2024

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

News Conference News ACC 2024

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

April 06, 2024

TAVI, SAVR Rates Roughly Equal for Patients Younger Than 65 in New England

News Conference News ACC 2024

TAVI, SAVR Rates Roughly Equal for Patients Younger Than 65 in New England

Yael L. Maxwell

April 05, 2024

Antihypertensives Linked to Lower Long-term Dementia Risk

News Daily News

Antihypertensives Linked to Lower Long-term Dementia Risk

April 01, 2024

CLIPPER: Emphasis on Faster Revascularization Could Change CLTI Care

News Conference News CRT 2024

CLIPPER: Emphasis on Faster Revascularization Could Change CLTI Care

March 20, 2024

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

News Daily News

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

March 15, 2024

Cognitive Impairment a Real Concern in HF Patients: HFSA

News Daily News

Cognitive Impairment a Real Concern in HF Patients: HFSA

March 13, 2024

FDA Grants MACE Reduction Indication for Semaglutide

News Daily News

FDA Grants MACE Reduction Indication for Semaglutide

March 08, 2024

Patients With CKD Remain Underrepresented in Trials of CV Meds

News Daily News

Patients With CKD Remain Underrepresented in Trials of CV Meds

March 08, 2024

Semaglutide Winning Streak Continues in CKD With FLOW

News Daily News

Semaglutide Winning Streak Continues in CKD With FLOW

March 06, 2024

One in Three Overweight MI Patients May Benefit From Semaglutide

News Daily News

One in Three Overweight MI Patients May Benefit From Semaglutide

February 26, 2024

Clinical Impact of Contrast-Induced Kidney Injury and Previous Kidney Disease in Patients Undergoing CTO PCI: Pooled Analysis of 2340 Patients From the LATAM CTO Registry

Presentation CTO 2024

Clinical Impact of Contrast-Induced Kidney Injury and Previous Kidney Disease in Patients Undergoing CTO PCI: Pooled Analysis of 2340 Patients From the LATAM CTO Registry

Presenter: Carlos Campos

February 02, 2024

Multiarterial Grafting in CABG Triumphs Again in Large Database Study

News Conference News STS 2024

Multiarterial Grafting in CABG Triumphs Again in Large Database Study

Yael L. Maxwell

January 29, 2024

New Machine Learning-Based Tool Predicts Individual Post-PCI Outcomes

News Daily News

New Machine Learning-Based Tool Predicts Individual Post-PCI Outcomes

Yael L. Maxwell

January 25, 2024

Lower Mortality With M-TEER vs Surgery, But Devil Is in the Details

News Daily News

Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details

Michael O'Riordan

January 25, 2024

Short Bouts of Physical Activity May Offset Occupational Sitting CVD Risks

News Daily News

Short Bouts of Physical Activity May Offset Occupational Sitting CVD Risks

January 24, 2024

AI Tools Can Flourish in CV Medicine, but Clinical Acumen Remains Key

News Conference News ISET 2024

AI Tools Can Flourish in CV Medicine, but Clinical Acumen Remains Key

January 23, 2024

DOAC Don’ts New Review Clarifies When Not to Use Direct Oral Anticoagulants

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

January 17, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.